IAVI and Moderna partner to tackle global health priorities using mRNA for vaccines and antibodies
Collaboration targets bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens and tuberculosis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
IAVI
IAVI, Merck KGaA and Serum Institute partner to develop COVID-19 mAbs
The partnership aims to ensure access to a class of innovative therapies that have, to date, been out of reach in low- and…